A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria

British Journal of Clinical Pharmacology

Volumn 45, Issue 2, 1998, Pages 123-129

  Batty, Kevin T ^a   Thu, Le Thi Anh ^b   Davis, Timothy M E ^a   Ilett, Kenneth F ^a   Mai, Truong Xuan ^b   Hung, Nguyen Canh ^c   Tien, Nguyen Phuc ^b   Powell, Shane M ^a   Thien, Huynh Van ^c   Binh, Tran Quang ^b   Kim, Nguyen Van ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CHO RAY HOSPITAL   (Viet Nam)

^c Bao Loc Hospital   (Viet Nam)

Author keywords

Artesunate; Bioavailability; Dihydroartemisinin; Falciparum malaria; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ARTESUNATE; DIHYDROARTEMISININ;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; ANTIMALARIALS; ARTEMISININS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALARIA, FALCIPARUM; MALE; REFERENCE VALUES; SESQUITERPENES; TIME FACTORS; VIETNAM;

EID: 0031963524     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00655.x     Document Type: Article

References (39)

1. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 347: 1654-1658.
2. Hien TT, White NJ. Qinghaosu. Lancet 1993; 341: 603-608.
3. de Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996; 52: 818-836.
4. White NJ. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans R Soc Trop Med Hyg 1994; 88 (Suppl 1): S41-S43.
5. Barradell LD, Fitton A. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 1995; 50: 714-741.
6. Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Bull WHO 1994; 72: 233-238.
7. Batty KT, Davis TME, Thu LTA, Binh TQ, Anh TK, Ilett KF. Selective high-performance liquid chromatographic determination of artesunate and α- and β-dihydroartemisinin in patients with falciparum malaria. J Chromatogr B 1996; 677: 345-350.
8. Yang SD, Ma JM, Sun JH, Chen DX, Song ZY. Clinical pharmacokinetics of a new effective antimalarial artesunate, a qinghaosu derivative. Chin J Clin Pharmacol 1985; 1: 106-109.
9. Zhao KC, Chen ZX, Lin BL, Guo XB, Li GQ, Song ZY. Studies on the phase 1 clinical pharmacokinetics of artesunate and artemether. Chin J Clin Pharmacol 1988; 4: 76-81.
10. Bethell DB, Teja-Isavadharm P, Phuong CXT, et al. Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1997; 91: 195-198.
11. Hien TT, Arnold K, Vinh H, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 1992; 86: 582-583.
12. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 1992; 339: 821-824.
13. Hien TT, Phu NH, Mai NTH, et al. An open randomized comparison of intravenous and intramuscular artesunate in severe falciparum malaria. Trans R Soc Trop Med Hyg 1992; 86: 584-585.
14. Looareesuwan S, Viravan C, Vanijanonta S, Wilairatana P, Pitisuttithum P, Andrial M. Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens. Am J Trop Med Hyg 1996; 54: 210-213.
15. Karbwang J, Na-Bangchang K, Thanavibul A, Ditta-in M, Bunnag D, Harinasuta T. Comparative clinical trial of artesunate and the combination of artesunate-mefloquine in multidrug-resistant falciparum malaria. Clin Drug Invest 1996; 11: 84-89.
16. Bunnag D, Kanda T, Karbwang J, Thimasarn K, Pungpak S, Harinasuta T. Artemether or artesunate followed by mefloquine as a possible treatment for multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1996; 90: 415-417.
17. Luxemburger C, ter Kuile FO, Nosten F, et al. Single day mefloquine-artesunate combination in the treatment of multidrug resistant falciparuin malaria. Trans R Soc Trop Med Hyg 1994; 88: 213-217.
18. Brewer TG, Grate SJ, Peggins JO, et al. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 1994; 51: 251-259.
19. Smith SL, Fishwick J, McLean WG, Edwards G, Ward SA. Enhanced in vitro neurotoxicity of artemisinin derivatives in the presence of haemin. Biochem Pharmacol 1997; 53: 5-10.
20. Kamchonwongpaisan S, McKeever P, Hossler P, Ziffer H, Meshnick SR. Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vitro. Am J Trop Med Hyg 1997; 56: 7-12.
21. Batty KT, Ilett KF, Davis TME. Chemical stability of artesunate injection and proposal for its administration by intravenous infusion. J Pharm Pharmacol 1996; 48: 22-26.
22. Thomann P. Non-compartmental analysis methods. In Topfit Version 2.0; Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC, Heinzel G, Woloszczak R, Thomann P, Stuttgart: Gustav Fischer, 1993.
23. Quinton A, Lebedev G, Youtz P, Tuerke T, Sinkler R, Kuo J. SigmaStat Version 2.0, San Rafael: Jandel Scientific, 1995.
24. Baird JD, Truswell AS. Nutritional factors in disease. In Davidson's Principles and Practice of Medicine, 15th Edition, eds Macleod J, Edwards C, Bouchier I, Edinburgh: Churchill Livingstone, 1987: 49-83.
25. Skinner TS, Manning LS, Johnston WA, Davis TME. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int J Parasitol 1996; 26: 519-525.
26. Hassan Alin M, Bjorkman A, Landberg-Lindgren A, Ashton M. The effect of artemisinin, its derivatives and mefloquine against chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1992; 86: 365-367.
27. Lee IS, Hufford CD. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther 1990; 48: 345-355.
28. Benakis A, Paris M, Plessas C, Hien TT, Waller D, White NJ. Pharmacokinetics of sodium artesunate after im and iv administration. Am J Trop Med Hyg 1993; 49 (Suppl): 293.
29. Benakis A, Paris M, Loutan L, Plessas CT, Plessas S. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. Am J Trop Med Hyg 1997; 56: 17-23.
30. Gibaldi M. Gastrointestinal Absorption-Biologic Considerations. In Biopharmaceutics and Clinical Pharmacokinetics, 4th Edition, Philadelphia: Lea & Febiger, 1991: 24-39.
31. Warrell DA, Molyneux ME, Beales PF. Severe and complicated malaria (2nd edition). Trans R Soc Trop Med Hyg 1990; 84 (Suppl 2): 1-65.
32. Hassan Alin M, Ashton M, Kihamia CM, Mtey GJ, Bjorkman A. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans R Soc Trop Med Hyg 1996; 90: 61-65.
33. Miller LG, Panosian CB. Ataxia and slurred speech after artesunate treatment for falciparum malaria. N Engl J Med 1997; 336: 1328.
34. Senanayake N, de Silva HJ. Delayed cerebellar ataxia complicating falciparum malaria: a clinical study of 74 patients. J Neurol 1994; 241: 456-459.
35. Mai NTH, Day NP, Ly VC, et al. Post-malaria neurological syndrome. Lancet 1996; 348: 917-921.
36. Luxemburger C, Nosten F, Raimond SD, Chongsuphajaisiddhi T, White NJ. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am J Trop Med Hyg 1995; 53: 522-525.
37. Hassan Alin M, Kihamia CM, Bjorkman A, et al. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium palciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine. Am J Trop Med Hyg 1995; 53: 639-645.
38. Duarte EC, Fontes CJ, Gyorkos TW, Abrahamowicz M. Randomized controlled trial of artesunate plus tetracycline versus standard treatment (quinine plus tetracycline) for uncomplicated Plasmodium falciparum malaria in Brazil. Am J Trop Med Hyg 1996; 54: 197-202.
39. Price RN, Nosten F, Luxemburger C, et al. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89: 523-527.